Our facility supports the transition from laboratory-scale pilot studies to large-scale production using established Quality-by-Design (QbD) systems. We ensure consistent yields and high purity levels, maintaining rigorous standards across all stages of the fermentation and purification process.
Next-IO™ T Cell related Therapeutics
Creative Biolabs provides a specialized array of services centered on the discovery and engineering of T-cell modulators. Our clients can expect to gain access to a robust library of monoclonal and bispecific antibodies targeting novel immune checkpoints, as well as advanced analytical workflows that decipher cell behavior at the single-cell level. By partnering with us, researchers gain the tools to overcome target heterogeneity and enhance the persistence of cell-based models, facilitating the identification of superior lead candidates for further investigation.
Introduction What We Can Offer How We Can Help Why Choose Us Customer Reviews FAQs Related Services Contact Us
Biological Principles of Next-Generation T Cell Modulators
T cell-related therapeutics represent a major focus in "Normalization Cancer Immunotherapy." Traditional research often fails because it addresses the immune system as a bulk population. However, recent literature emphasizes that single-cell resolution is helpful to decipher the "Ideal Therapeutic T cell." By targeting non-redundant checkpoints (FGL1, VISTA) and utilizing conditional co-stimulators, researchers can now engineer cells that persist as memory populations in model systems. Creative Biolabs' platform is built on these peer-reviewed principles to ensure your research survives the biological hurdles of the tumor microenvironment.
Request a Consultation →
Fig.1 Overview of Td immunogenicity. 1
What We Can Offer
Scalable Bioprocessing
High-Resolution Multi-Omic Mapping
Our platform delivers simultaneous characterization of TCR sequences, transcriptomes, and chromatin accessibility. This high-dimensional data allows researchers to predict cell "fate" and differentiation pathways within complex laboratory environments with unprecedented clarity.
Next-Generation Target Portfolio
Gain immediate access to our specialized developmental programs for non-redundant checkpoints, including FGL1, Siglec-15, VISTA, and TMIGD2. These tools are specifically designed to investigate immune evasion mechanisms that operate independently of the PD-1/PD-L1 axis.
Iterative Research Feedback Loops
By applying single-cell technologies to biological samples, we identify critical markers of response and resistance. This iterative approach allows for rapid program pivoting, ensuring that your research lead candidates are continuously optimized based on real-time data.
How Creative Biolabs Can Assist Your Project
Creative Biolabs provides an integrated pipeline designed to move beyond broad immune activation toward high-dimensional precision. Whether you are developing an agonistic monoclonal antibody for co-stimulation or a complex bispecific T-cell engager, we offer the specific data and constructs required for pre-clinical evaluation. We solve the critical "Anergy vs. Activation" dilemma by providing structural and functional validation that ensures your candidate provides the necessary "Signal 2" for durable T-cell memory in experimental models. We offer a broad portfolio of developmental programs, including:
Bispecific →
Bispecific T-Cell Engager →
Highlights
Single-Cell Resolution
We move beyond bulk data to identify exactly which T-cell clones respond to your candidate, providing a high-resolution map of cell behavior and transcriptional health.
Superior Analytical Precision
Our platform integrates transcriptomic and epigenetic profiling to distinguish between short-term effector states and long-term memory potential, ensuring the selection of robust leads.
Optimized Molecule Design
Our CD28-bispecifics and TCR-directed ADCs are engineered to maximize target-specific potency while minimizing non-specific activation in both in vitro and in vivo models.
Proven Technical Expertise
By combining innovative protein engineering with advanced imaging, we provide the deep mechanistic data required to validate your most complex T-cell modulation strategies.
Reach out to our experts to discuss a tailored service package that aligns with your specific research timeline and technical requirements.
Customer Reviews
-
Superior TCR Specificity
Using Creative Biolabs' TCR-directed ADC platform in our research has facilitated the elimination of specific T-cell clones in experimental models while sparing the healthy repertoire. Their internalization kinetic data was instrumental for our program. - Dr. S**h. W. -
Single-Cell Insights
Integrating Creative Biolabs' multi-omic profiling allowed us to identify why our cell product was failing in solid tumor assays. We discovered a specific STUB1-mediated exhaustion pathway that we have since successfully edited. - Prof. M**l. K.
FAQs
What makes FGL1 a target of interest compared to traditional LAG-3 binders?
FGL1 is a major MHC-II independent ligand. Blockade of the FGL1/LAG-3 axis can restore T-cell function in experimental models even when the target cells have downregulated MHC-II, providing a distinct pathway for investigating immune resistance mechanisms.
Can your platform assist with allogeneic T-cell research?
Yes. We utilize STUB1 and CHIC2 modulation to investigate the persistence and characteristics of "off-the-shelf" products in laboratory settings, helping researchers understand how to maintain engineered cell functionality within diverse and complex immunosuppressive experimental microenvironments.
Related Services
Next-IO™ CCL2/CCR2 Axis Targeted Therapeutic Antibody Program
Specialized antibody development to modulate chemokine-mediated recruitment of immunosuppressive myeloid cells and enhance T-cell infiltration within experimental tumor microenvironments.
Learn More →COVID-19 Recovered Patient-Derived Anti-SARS-CoV-2 Therapeutic Antibody Development
High-throughput identification and characterization of neutralizing antibodies from high-titer donors to support research into viral epitope mapping and the development of potent experimental reagents.
Learn More →How to Contact Us
Creative Biolabs provides an advanced suite of T cell-related therapeutics for research applications, ranging from non-redundant checkpoint antibodies to complex conditional co-stimulators. By integrating single-cell multi-omics with innovative protein engineering, we ensure your research pipeline is positioned for success.
Our scientific experts are available to discuss your specific target requirements, providing deep insights into the functional attributes of your lead candidates. We invite you to reach out to our team.
Reference
- Jawa, Vibha et al. "T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation-Updated Consensus and Review 2020." Frontiers in immunology vol. 11 1301. 30 Jun. 2020. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2020.01301
Download our brochureLoading case studies...
Online Inquiry